| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |